Patent ID: 7144578

Claim:
A recombinant poxvirus that contains and expresses exogenous DNA encoding rabies glycoprotein G, wherein the recombinant poxvirus is a vaccinia virus that has deleted therefrom or disrupted therein J2R, B13R+B14R, A26L, A56R, C7L−K1L and I4L, or the recombinant poxvirus is a vaccinia virus that has deleted therefrom or disrupted therein a thymidine kinase gene, a hemorrhagic region, an A type inclusion body region, a hemagglutinin gene, a host range region, and a large subunit, ribonucleotide reductase, or the recombinant poxvirus is a NYVAC virus, or a poxvirus having all of the identifying characteristics of a NYVAC virus, or the recombinant poxvirus is an ALVAC virus, or a poxvirus having all of the identifying characteristics of an ALVAC virus.